IL2 and breast cancer: It was shown that, compared with healthy controls, in the saliva of breast cancer patients, there is an increase in the content of both pro-inflammatory (IL-2, IL-6, and IL-18) and anti-inflammatory cytokines (IL-4 and IL-10).